SCHEMBL5928481

SCHEMBL5928481

COc1cccc(C(C)(C)NC[C@@H](OC=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2)c1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL5928477 0.87 CTSD (0.78) CTSD
SCHEMBL5383205 0.87 CTSD (0.83) CTSD
SCHEMBL18767101 0.81 CTSD (0.79) CTSD
SCHEMBL5222370 0.80 BACE1 (0.69) CTSD
SCHEMBL5930472 0.79 CTSD (0.69) CTSD
SCHEMBL5930389 0.78 BACE1 (0.70) CTSD
SCHEMBL5930014 0.78 CTSD (0.56) CTSD
SCHEMBL23532638 0.77 CTSD (0.55) CTSD
SCHEMBL30029022 0.77 CTSD (0.55) CTSD
SCHEMBL23532640 0.77 CTSD (0.55) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060211740-A1 Novel compounds GLAXO GROUP LIMITED 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211740-A1 Novel compounds BACE2, BACE1, PSEN2 CTSD 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.